Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Amortizatization of Intangibles (2017 - 2024)

Solid Biosciences' Amortizatization of Intangibles history spans 8 years, with the latest figure at $803000.0 for Q4 2024.

  • For Q4 2024, Amortizatization of Intangibles fell 30.23% year-over-year to $803000.0; the TTM value through Dec 2024 reached $3.6 million, up 49.17%, while the annual FY2024 figure was $3.6 million, 49.17% up from the prior year.
  • Amortizatization of Intangibles for Q4 2024 was $803000.0 at Solid Biosciences, down from $1.2 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.2 million in Q3 2024 and bottomed at -$582000.0 in Q4 2021.
  • The 5-year median for Amortizatization of Intangibles is $136500.0 (2023), against an average of $292312.5.
  • The largest annual shift saw Amortizatization of Intangibles crashed 101.15% in 2020 before it surged 5688.24% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$1000.0 in 2020, then crashed by 58100.0% to -$582000.0 in 2021, then surged by 147.42% to $276000.0 in 2022, then surged by 317.03% to $1.2 million in 2023, then crashed by 30.23% to $803000.0 in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Amortizatization of Intangibles are $803000.0 (Q4 2024), $1.2 million (Q3 2024), and $1.0 million (Q2 2024).